BMJ28d
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management
Antimyelin-associated glycoprotein (MAG) neuropathy is a rare autoimmune demyelinating peripheral neuropathy caused by IgM autoantibodies targeting MAG. The typical presentation is that of a slowly ...
BMJ1d
White-matter diffusion abnormalities in temporal-lobe epilepsy with and without mesial temporal sclerosis
Division of Neurology, Department of Medicine, University of Alberta, Alberta, Canada Dr D W Gross, Division of Neurology, Department of Medicine, 2E3.19 Walter C Mackenzie Health Sciences Centre, ...
BMJ1d
Use of antidepressants and the risk of Parkinson’s disease: a prospective study
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Dr A Alonso, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, ...
BMJ1d
The grasp and other primitive reflexes
1 Dementia Research Group, Institute of Neurology, University College, London, UK 2 Dementia Research Group, Institute of Neurology, University College, London; and Division of Neuroscience and ...
BMJ4d
Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes
Correspondence to Dr Michael A van Es, Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands; M.A.vanEs{at}umcutrecht.nl Objectives ...
BMJ4d
Tumefactive demyelination: an approach to diagnosis and management
2 Queen Square MS Centre, Institute of Neurology, University College London, London, UK Correspondence to Dr Todd Hardy, Box 21, National Hospital for Neurology and Neurosurgery, Queen Square, London ...
BMJ4d
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
From 1979-85, 2435 patients with a transient ischaemic attack or minor ischaemic stroke were randomly allocated to receive long term "blind" treatment with aspirin 600 mg twice daily (n = 815), ...
BMJ4d
A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis
Objective: Identifying and effectively treating erectile dysfunction (ED) can result in an improvement of the quality of life (QoL) in men with multiple sclerosis (MS). Methods: This randomised, ...
BMJ2d
EEG in the diagnosis, classification, and management of patients with epilepsy
The human electroencephalogram (EEG) was discovered by the German psychiatrist, Hans Berger, in 1929. Its potential applications in epilepsy rapidly became clear, when Gibbs and colleagues in Boston ...
BMJ13d
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
Background Over the decades, several natural history studies on patients with primary (PPMS) or secondary progressive multiple sclerosis (SPMS) were reported from international registries. In PPMS, a ...
BMJ6d
Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
Background: Neuromyelitis optica (NMO) is a neurological inflammatory disease associated with autoimmunity to aquaporin 4, predominantly localised in astrocytic foot processes. Recent studies have ...
BMJ3d
Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function
Dr Gavin Giovannoni, University Department of Clinical Neurosciences, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF. Telephone 0044 171 794 ...